Aquaculture Vaccines Market is expected to grow at a CAGR of 9.4% during 2020-2026

The research report "Aquaculture Vaccines Market by vaccine type (Inactivated vaccine, attenuated live vaccine, DNA vaccine, and others), by application (bacterial Infection, viral Infection, combined bacterial and viral Infections, and others), by route of administration (Immersion vaccines, Injection vaccines, and oral vaccines), by species (salmon, seabass and seabream, tilapia, trout, turbot, and carp) and geography – global/region/country forecast to 2026."

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Aquaculture vaccines market by vaccine type, application, route of administration, species and geography – global/region/country forecast to 2026"

View detailed report description at https://precisionbusinessinsights.com/market-reports/aquaculture-vaccines-market/

The global aquaculture vaccines market was worth US 371.8 million in 2019 and is expected to grow at a 9.4% compound annual growth rate (CAGR) due to the increase in the acceptance of feed additives for aquaculture species, increase in the seafood demand, rise in the occurrence of aquaculture illnesses and newly launched advanced products. Aquaculture vaccines market growth is due to an increase in the number of various aquaculture diseases which led to increase in investment of research and development to introduce new vaccines by the market leaders. The introduction of new species to meet the consumption of fish in humans which increases the development of new aquaculture diseases contributing to the growth of the aquaculture market. To increase the life span and immune system of fish vaccines are used by the farmers and also rise in bacterial infections and viral infections which are the major factors for the aquaculture vaccines market during the forecast period. However new approvals and regulations for the development of vaccines hamper the growth of the market.

Impact of COVID-19 on Aquaculture Vaccines Market:
In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years.

Europe Dominates the Aquaculture Vaccine Market:
Europe is dominated the aquaculture vaccine market compared to all the regions. It contributes major share in the global during the forecast period. Norway aquaculture vaccines market is increasing due to rise in fish farming companies, it alone produced 48.0% salmon species among the global production. In the asia pacific region the adoption of aquaculture vaccines is increased in china due to the production of carp, seabass seabream and tilapia. Additionally aquaculture industry is considered as major source of protein for humans and also technological changes in development of vaccines fuels the market growth.

Request a case study or sample research report at https://precisionbusinessinsights.com/request-sample?product_id=42803

Merck acquired Vaki, an aquaculture equipment company to improve the efficiency of animal health. Hipra launched a new vaccine to tackle nodavirus. Virbac partnered with Ictyogroup to improve the vaccines for tilapia and recently it also launched its research and development center in Vietnam. Salmon Rickettsial Septicaemia (SRS) Syndrome a major disease in salmons to control the spread vaccines was introduced by Pharmaq and Zoetis

Key market players covered in this report are Pharmaq AS, Merck Animal Health, KoVax, Hipra, Tecnovax SA, Veterquimica S.A., Nisseiken Co., Ltd. and Virbac

Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership. Capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide

This release was published on openPR.